Condition: Syphilis, Congenital · Sponsor: London School of Hygiene and Tropical Medicine
CARES-1 is a randomised, open-label, phase II pharmacokinetic (PK) and safety study of ambulatory antibiotics for the treatment of neonates with "all-risk" asymptomatic congenital syphilis.
This description comes directly from the study's public registry record.
Sarah Prentice · +4420 7636 8636 · sarah.prentice@lshtm.ac.uk
Always discuss trial participation with your own doctor first.
| Universitas Indonesia | Jakarta, Indonesia | Not Yet Recruiting |
| Malawi Liverpool Wellcome Programme | Blantyre, Malawi | Not Yet Recruiting |
| Stellenbosch | Stellenbosch, South Africa | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06921213